A man with localised prostate cancer has Cambridge Prognostic Group 4 disease and wishes to avoid external-beam radiotherapy. Which brachytherapy

Question

A man with localised prostate cancer has Cambridge Prognostic Group 4 disease and wishes to avoid external-beam radiotherapy. Which brachytherapy statement follows NICE NG131?

Accepted Answer

Do not use brachytherapy alone; combine it with external-beam radiotherapy in selected patients

Answer

Use low-dose-rate brachytherapy alone as an equivalent option for CPG 4 disease

Answer

Exclude brachytherapy in all CPG 4 and 5 disease, including use as a boost

Answer

Use brachytherapy alone when androgen-deprivation therapy is prescribed for six months

Answer

Use high-dose-rate brachytherapy alone when MRI suggests organ-confined disease

LDR Brachytherapy Prostate — SCE Medical Oncology MCQ

A man with localised prostate cancer has Cambridge Prognostic Group 4 disease and wishes to avoid external-beam radiotherapy. Which brachytherapy statement follows NICE NG131?